ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 530,11
0,36%
Dow Jones
38 542,05
-0,12%
DAX
18 031,66
0,06%
Brent Oil
82,955
1,01%
Bitcoin
65 408,14
-1,85%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Organogenesis Holdings Inc (ORGO)

  7. Organogenesis Holdings Inc (ORGO) Actualités

ORGO

Organogenesis (ORGO)

Organogenesis Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ORGO
DateHeureSourceTitreSymboleSociété
06/06/202422h05GlobeNewswire Inc.Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech ConferenceNASDAQ:ORGOOrganogenesis Holdings Inc
09/05/202422h25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORGOOrganogenesis Holdings Inc
09/05/202422h05GlobeNewswire Inc.Organogenesis Holdings Inc. Reports First Quarter 2024 Financial ResultsNASDAQ:ORGOOrganogenesis Holdings Inc
02/05/202413h00GlobeNewswire Inc.Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee OsteoarthritisNASDAQ:ORGOOrganogenesis Holdings Inc
16/04/202413h30GlobeNewswire Inc.Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024NASDAQ:ORGOOrganogenesis Holdings Inc
03/04/202413h30GlobeNewswire Inc.Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud CaseNASDAQ:ORGOOrganogenesis Holdings Inc
29/02/202422h31Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ORGOOrganogenesis Holdings Inc
29/02/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGOOrganogenesis Holdings Inc
29/02/202422h05GlobeNewswire Inc.Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 GuidanceNASDAQ:ORGOOrganogenesis Holdings Inc
23/02/202423h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
12/02/202413h30GlobeNewswire Inc.Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools ConferenceNASDAQ:ORGOOrganogenesis Holdings Inc
08/02/202422h05GlobeNewswire Inc.Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024NASDAQ:ORGOOrganogenesis Holdings Inc
02/02/202415h54Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ORGOOrganogenesis Holdings Inc
09/01/202422h43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
09/11/202322h05GlobeNewswire Inc.Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial ResultsNASDAQ:ORGOOrganogenesis Holdings Inc
05/10/202313h30GlobeNewswire Inc.Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023NASDAQ:ORGOOrganogenesis Holdings Inc
28/09/202315h15GlobeNewswire Inc.Organogenesis Applauds Withdrawal of Local Coverage Determinations by Novitas, First Coast Service Options and CGSNASDAQ:ORGOOrganogenesis Holdings Inc
06/09/202322h05GlobeNewswire Inc.Organogenesis Holdings Inc. to Participate in the Morgan Stanley 21st Annual Global Healthcare ConferenceNASDAQ:ORGOOrganogenesis Holdings Inc
09/08/202322h05GlobeNewswire Inc.Organogenesis Holdings Inc. Reports Second Quarter 2023 Financial Results; Withdraws Fiscal Year 2023 GuidanceNASDAQ:ORGOOrganogenesis Holdings Inc
10/07/202313h30GlobeNewswire Inc.Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2023 Financial Results on August 9, 2023NASDAQ:ORGOOrganogenesis Holdings Inc
10/05/202322h48Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ORGOOrganogenesis Holdings Inc
10/05/202322h23Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORGOOrganogenesis Holdings Inc
10/05/202322h05GlobeNewswire Inc.Organogenesis Holdings Inc. Reports First Quarter 2023 Financial ResultsNASDAQ:ORGOOrganogenesis Holdings Inc
01/05/202322h13Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ORGOOrganogenesis Holdings Inc
01/05/202322h10Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ORGOOrganogenesis Holdings Inc
27/04/202313h30GlobeNewswire Inc.Organogenesis President and Chief Executive Officer Gary S. Gillheeney, Sr. Elected Chair of the Board of DirectorsNASDAQ:ORGOOrganogenesis Holdings Inc
15/04/202300h28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORGOOrganogenesis Holdings Inc
10/04/202313h30GlobeNewswire Inc.Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2023 Financial Results on May 10, 2023NASDAQ:ORGOOrganogenesis Holdings Inc
06/04/202315h31Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ORGOOrganogenesis Holdings Inc
27/03/202314h00GlobeNewswire Inc.Organogenesis Applauds Findings from the Office of Inspector GeneralNASDAQ:ORGOOrganogenesis Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:ORGO

Dernières Valeurs Consultées

EU
EN
Bouygues
EU
RNO
Renault
NYSE
NKE
Nike
EU
HO
Thales
EU
ML
Michelin
EU
SGO
Cie de SaintGobain
NYSE
MCD
McDonalds
EU
ORA
Orange
EU
MC
Lvmh Moet Hennessy Louis...
EU
CAP
Capgemini
NYSE
KO
Coca Cola
NASDAQ
AAPL
Apple
EU
AI
Air Liquide
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés